Galmiche J P, Zerbib F, Bruley des Varannes S
CHU Nantes, Service Hépato-Gastroentérologie, Institut des Maladies de l'Appareil Digestif and Institut National de Santé et de Recherche Médicale, Nantes, France.
Aliment Pharmacol Ther. 2008 Mar 15;27(6):449-64. doi: 10.1111/j.1365-2036.2008.03611.x. Epub 2008 Jan 11.
Respiratory manifestations represent one of the most prevalent and difficult-to-manage extra-oesophageal syndromes of gastro-oesophageal reflux disease.
To review the epidemiology, pathophysiological mechanisms and therapeutic outcomes of reflux-related respiratory disorders.
Search of the literature published in English using PubMed database.
There is a discrepancy between the high prevalence of reflux in asthmatics and the limited efficacy of antireflux therapies. Asthma per se may cause reflux. Patients with difficult-to-treat asthma and/or nocturnal symptoms should be screened for reflux. Reflux can induce chronic cough through different mechanisms including micro-aspiration and both local and central reflexes. Cough and reflux may precipitate each other. A meta-analysis found no significant difference between placebo and proton pump inhibitors in the resolution of cough. Encouraging results have been reported, following antireflux surgery in patients selected on the basis of pH-impedance monitoring. Attention has been drawn to obstructive sleep apnoea syndrome.
The role of gastro-oesophageal reflux disease in the pathogenesis of miscellaneous respiratory disorders has been discussed for decades and established in asthma and cough. However, no major therapeutic advances have been reported recently. Future trials should concentrate on patient selection and the control of efficacy using recently developed technologies, such as pH-impedance monitoring.
呼吸道表现是胃食管反流病最常见且最难处理的食管外综合征之一。
综述反流相关呼吸道疾病的流行病学、病理生理机制及治疗效果。
使用PubMed数据库检索英文发表的文献。
哮喘患者中反流的高患病率与抗反流治疗的有限疗效之间存在差异。哮喘本身可能导致反流。难治性哮喘和/或夜间症状的患者应筛查反流情况。反流可通过不同机制诱发慢性咳嗽,包括微误吸以及局部和中枢反射。咳嗽和反流可能相互促发。一项荟萃分析发现,在咳嗽缓解方面,安慰剂与质子泵抑制剂之间无显著差异。基于pH阻抗监测选择的患者进行抗反流手术后,已报告了令人鼓舞的结果。阻塞性睡眠呼吸暂停综合征已受到关注。
胃食管反流病在多种呼吸道疾病发病机制中的作用已讨论数十年,并在哮喘和咳嗽中得到证实。然而,最近尚未有重大治疗进展的报道。未来的试验应集中于患者选择以及使用最近开发的技术(如pH阻抗监测)来控制疗效。